Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Important and specific role for basophils in acute allergic reactions.

Korošec P, Gibbs BF, Rijavec M, Custovic A, Turner PJ.

Clin Exp Allergy. 2018 May;48(5):502-512. doi: 10.1111/cea.13117. Epub 2018 Mar 23. Review.

3.

Inhibition of IgE-mediated allergic reactions by pharmacologically targeting the circadian clock.

Nakamura Y, Nakano N, Ishimaru K, Ando N, Katoh R, Suzuki-Inoue K, Koyanagki S, Ogawa H, Okumura K, Shibata S, Nakao A.

J Allergy Clin Immunol. 2016 Apr;137(4):1226-1235. doi: 10.1016/j.jaci.2015.08.052. Epub 2015 Nov 11.

PMID:
26559325
4.

Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.

Eggel A, Baravalle G, Hobi G, Kim B, Buschor P, Forrer P, Shin JS, Vogel M, Stadler BM, Dahinden CA, Jardetzky TS.

J Allergy Clin Immunol. 2014 Jun;133(6):1709-19.e8. doi: 10.1016/j.jaci.2014.02.005. Epub 2014 Mar 15.

5.

An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.

Wigginton SJ, Furtado PB, Armour KL, Clark MR, Robins A, Emara M, Ghaemmaghami AM, Sewell HF, Shakib F.

Clin Exp Allergy. 2008 Feb;38(2):313-9. Epub 2007 Dec 7.

PMID:
18070161
6.

Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils.

Song Y, Qu C, Srivastava K, Yang N, Busse P, Zhao W, Li XM.

J Allergy Clin Immunol. 2010 Dec;126(6):1208-17.e3. doi: 10.1016/j.jaci.2010.09.013.

7.

Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge.

Christensen LH, Holm J, Lund G, Riise E, Lund K.

J Allergy Clin Immunol. 2008 Aug;122(2):298-304. doi: 10.1016/j.jaci.2008.05.026. Epub 2008 Jun 24.

PMID:
18572230
8.

Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies.

Zhang K, Liu J, Truong T, Zukin E, Chen W, Saxon A.

J Immunol. 2017 May 15;198(10):3823-3834. doi: 10.4049/jimmunol.1602022. Epub 2017 Apr 10.

9.

IL-33 is a mediator rather than a trigger of the acute allergic response in humans.

Fux M, Pecaric-Petkovic T, Odermatt A, Hausmann OV, Lorentz A, Bischoff SC, Virchow JC, Dahinden CA.

Allergy. 2014 Feb;69(2):216-22. doi: 10.1111/all.12309. Epub 2013 Nov 11.

PMID:
24205920
10.

IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.

Zellweger F, Buschor P, Hobi G, Brigger D, Dahinden CA, Villiger PM, Eggel A.

Cell Death Dis. 2018 May 1;9(5):510. doi: 10.1038/s41419-018-0526-9.

11.

Distinct Contributory Factors Determine Basophil-Allergen Sensitivity in Grass Pollen Rhinitis and in Anaphylactic Wasp Venom Allergy.

Korošec P, Šilar M, Kopač P, Eržen R, Zidarn M, Košnik M.

Int Arch Allergy Immunol. 2016;171(2):89-101. doi: 10.1159/000452102. Epub 2016 Dec 2.

12.

Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.

Cemerski S, Chu SY, Moore GL, Muchhal US, Desjarlais JR, Szymkowski DE.

Immunol Lett. 2012 Mar 30;143(1):34-43. doi: 10.1016/j.imlet.2012.01.008. Epub 2012 Jan 25.

PMID:
22305932
13.

CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation.

Sabato V, Verweij MM, Bridts CH, Levi-Schaffer F, Gibbs BF, De Clerck LS, Schiavino D, Ebo DG.

Cytometry B Clin Cytom. 2012 May;82(3):132-8. doi: 10.1002/cyto.b.21003. Epub 2011 Dec 15.

14.

A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.

Zellweger F, Gasser P, Brigger D, Buschor P, Vogel M, Eggel A.

Allergy. 2017 Aug;72(8):1174-1183. doi: 10.1111/all.13109. Epub 2017 Jan 24.

PMID:
27997998
15.

Human IgE-independent systemic anaphylaxis.

Finkelman FD, Khodoun MV, Strait R.

J Allergy Clin Immunol. 2016 Jun;137(6):1674-1680. doi: 10.1016/j.jaci.2016.02.015. Epub 2016 Apr 26. Review.

PMID:
27130857
16.

Basophils from allergic patients are neither hyperresponsive to activation signals nor hyporesponsive to inhibition signals.

Cassard L, Sperber K, Buivan TP, Cotillard A, Bourdet-Sicard R, Albert ML, Mottez E, Laurent J, Guinnepain MT, Daëron M.

J Allergy Clin Immunol. 2018 Nov;142(5):1548-1557. doi: 10.1016/j.jaci.2017.11.053. Epub 2018 Jan 31.

PMID:
29366701
17.

Pretreatment with low levels of FcεRI-crosslinking stimulation enhances basophil mediator release.

Koketsu R, Yamaguchi M, Suzukawa M, Tanaka Y, Tashimo H, Arai H, Nagase H, Matsumoto K, Saito H, Ra C, Yamamoto K, Ohta K.

Int Arch Allergy Immunol. 2013;161 Suppl 2:23-31. doi: 10.1159/000350339. Epub 2013 May 29.

PMID:
23711850
18.

New insights into the roles for basophils in acute and chronic allergy.

Mukai K, Obata K, Tsujimura Y, Karasuyama H.

Allergol Int. 2009 Mar;58(1):11-9. doi: 10.2332/allergolint.08-RAI-0059. Epub 2009 Jan 25. Review.

19.

Basophils in inflammation.

Schwartz C, Eberle JU, Voehringer D.

Eur J Pharmacol. 2016 May 5;778:90-5. doi: 10.1016/j.ejphar.2015.04.049. Epub 2015 May 7. Review.

PMID:
25959388
20.

Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis.

Korosec P, Turner PJ, Silar M, Kopac P, Kosnik M, Gibbs BF, Shamji MH, Custovic A, Rijavec M.

J Allergy Clin Immunol. 2017 Sep;140(3):750-758.e15. doi: 10.1016/j.jaci.2016.12.989. Epub 2017 Mar 22.

Supplemental Content

Support Center